Clinical Trial Update: 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 13-cis retinoic acid with or without vitamin E for prevention of lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• 13-cis-retinoic acid (13-cis-retinoic acid)
• Vitamin E (tocopherol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Drug Toxicity, Lung Cancer | Phase 2 | Status: COMPLETED